av/telo-genomics--big.svg

TSX:TELO

Telo Genomics Corp.

  • Stock

Last Close

0.20

30/08 17:22

Volume Today

500

Avg: 17.66K

PE Ratio

−3.97

PFCF: −4.28

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
average inventory
average payables
371.77K
-
885.53K
138.20%
690.47K
22.03%
176.71K
74.41%
average receivables
7.26K
-
6.77K
6.80%
129.19K
1,809.40%
292.66K
126.54%
186.54K
36.26%
38.57K
79.33%
42.93K
11.32%
73.00K
70.03%
67.35K
7.73%
50.87K
24.47%
book value per share
0.12
-
0.11
8.92%
0.13
20.51%
0.05
63.70%
-0.01
111.25%
-0.08
1,403.75%
0.03
132.79%
0.08
203.44%
0.04
43.54%
0.04
2.12%
capex per share
-0.01
-
-0.00
96.13%
-0.00
-
-0.00
31.47%
-0.00
116.30%
-0.00
167.34%
capex to depreciation
-4.33
-
-0.19
95.70%
-0.13
-
-0.15
11.67%
-0.44
195.65%
-2.09
371.51%
capex to operating cash flow
0.06
-
0.01
88.05%
0.01
-
0.01
8.83%
0.01
66.51%
0.03
87.13%
capex to revenue
cash per share
0.12
-
0.11
8.36%
0.07
33.80%
0.03
65.20%
0.00
95.52%
0.00
30.85%
0.03
1,987.60%
0.08
152.03%
0.05
40.81%
0.04
3.19%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
1.07
-
0.03
96.79%
0.01
69.56%
0.01
35.51%
0.01
21.31%
debt to equity
-0.27
-
0.05
119.25%
0.01
78.97%
0.02
41.58%
0.01
19.05%
dividend yield
earnings yield
-0.01
-
-0.06
711.69%
-0.02
72.63%
-0.09
415.83%
-0.10
11.18%
-0.65
541.13%
-0.17
73.40%
-0.05
73.60%
-0.10
120.51%
-0.16
57.96%
enterprise value
4.17M
-
1.22M
70.64%
3.65M
197.85%
107.55M
2,850.19%
46.25M
56.99%
1.91M
95.86%
6.30M
229.31%
19.85M
214.96%
18.32M
7.71%
15.10M
17.55%
enterprise value over ebitda
-250.29
-
-10.94
95.63%
-49.60
353.31%
-12.53
74.75%
-10.56
15.70%
-1.97
81.33%
-5.48
177.83%
-19.62
258.22%
-8.92
54.54%
-5.42
39.26%
ev to operating cash flow
-117.51
-
-11.46
90.24%
-46.35
304.33%
-13.61
70.63%
-14.43
5.96%
-5.84
59.53%
-5.63
3.57%
-17.97
219.24%
-10.21
43.21%
-5.74
43.72%
ev to sales
free cash flow per share
-0.01
-
-0.03
203.88%
-0.02
29.59%
-0.18
883.60%
-0.05
69.24%
-0.02
54.12%
-0.04
52.08%
-0.02
36.99%
-0.03
30.62%
-0.04
44.59%
free cash flow yield
-0.01
-
-0.06
735.68%
-0.02
68.71%
-0.08
288.26%
-0.07
9.50%
-0.20
184.43%
-0.16
20.79%
-0.05
69.75%
-0.09
82.69%
-0.15
75.22%
graham net net
0.12
-
0.11
8.84%
0.11
1.00%
0.01
89.00%
-0.01
191.45%
-0.10
782.15%
0.02
119.79%
0.08
302.00%
0.04
43.99%
0.04
5.73%
graham number
0.15
-
0.25
63.96%
0.21
13.85%
0.47
117.79%
0.10
79.38%
0.38
294.33%
0.16
59.08%
0.20
29.19%
0.19
5.65%
0.21
12.95%
income quality
0.95
-
0.98
2.96%
1.12
14.34%
0.80
29.02%
0.68
14.29%
0.31
55.32%
0.90
195.43%
1.03
14.49%
0.85
17.61%
0.93
9.60%
intangibles to total assets
0
-
0
0
0
0
0
0.01
Infinity%
0.00
69.56%
0.01
35.51%
0.01
3.16%
interest coverage
-45.79
-
interest debt per share
0.02
-
0.00
89.50%
0.00
61.63%
0.00
20.07%
0.00
20.76%
inventory turnover
invested capital
-0.27
-
0.05
119.25%
0.01
78.97%
0.02
41.58%
0.01
19.05%
market cap
4.67M
-
1.68M
63.98%
3.96M
135.41%
108.75M
2,643.39%
46.32M
57.40%
1.65M
96.43%
7.18M
334.49%
23.44M
226.40%
20.97M
10.55%
17.74M
15.38%
net current asset value
497.97K
-
449.24K
9.79%
566.45K
26.09%
1.31M
131.69%
-576.64K
143.94%
-1.22M
112.36%
643.89K
152.58%
3.61M
460.21%
2.56M
29.13%
2.53M
1.03%
net debt to ebitda
30.43
-
4.11
86.48%
4.33
5.41%
0.14
96.77%
0.02
89.01%
-0.27
1,846.02%
0.77
385.32%
3.56
364.32%
1.29
63.67%
0.95
26.68%
net income per share
-0.01
-
-0.03
195.16%
-0.02
38.42%
-0.21
1,206.77%
-0.08
62.21%
-0.08
3.41%
-0.04
48.92%
-0.02
45.00%
-0.04
57.66%
-0.05
30.34%
operating cash flow per share
-0.01
-
-0.03
203.88%
-0.02
29.59%
-0.17
827.51%
-0.05
67.61%
-0.02
53.79%
-0.04
50.91%
-0.02
37.03%
-0.03
29.90%
-0.04
42.86%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.07
-
-0.23
223.18%
-0.12
50.12%
-3.18
2,633.71%
-10.93
243.20%
-4.09
62.58%
-1.08
73.65%
-0.28
74.03%
-0.75
167.69%
-0.97
29.41%
revenue per share
roe
-0.07
-
-0.24
224.07%
-0.12
48.90%
-4.45
3,500.22%
14.95
435.78%
1.03
93.12%
-1.60
255.79%
-0.29
81.87%
-0.81
179.26%
-1.08
33.17%
roic
-0.03
-
-0.25
613.44%
-0.13
47.89%
-4.44
3,318.68%
14.65
430.21%
1.38
90.60%
-1.64
218.87%
-0.34
79.38%
-0.80
136.49%
-1.07
33.55%
sales general and administrative to revenue
shareholders equity per share
0.12
-
0.11
8.92%
0.13
20.51%
0.05
63.70%
-0.01
111.25%
-0.08
1,403.75%
0.03
132.79%
0.08
203.44%
0.04
43.54%
0.04
2.12%
stock based compensation to revenue
tangible asset value
497.97K
-
449.24K
9.79%
566.45K
26.09%
2.23M
293.07%
-314.02K
114.10%
-1.04M
232.74%
758.88K
172.63%
3.67M
383.50%
2.59M
29.50%
2.60M
0.37%
tangible book value per share
0.12
-
0.11
8.92%
0.13
20.51%
0.05
63.70%
-0.01
111.25%
-0.08
1,403.75%
0.03
132.79%
0.08
203.44%
0.04
43.54%
0.04
2.12%
working capital
497.97K
-
449.24K
9.79%
566.45K
26.09%
1.33M
134.69%
-576.64K
143.38%
-1.22M
112.36%
683.89K
155.85%
3.65M
433.29%
2.60M
28.81%
2.56M
1.31%

All numbers in (except ratios and percentages)